Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 65
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Int J Mol Sci ; 23(4)2022 Feb 11.
Artículo en Inglés | MEDLINE | ID: mdl-35216125

RESUMEN

The development of floral organs is coordinated by an elaborate network of homeotic genes, and gibberellin (GA) signaling is involved in floral organ development; however, the underlying molecular mechanisms remain elusive. In the present study, we found that MOS4-ASSOCIATED COMPLEX 5A (MAC5A), which is a protein containing an RNA-binding motif, was involved in the development of sepals, petals, and stamens; either the loss or gain of MAC5A function resulted in stamen malformation and a reduced seed set. The exogenous application of GA considerably exacerbated the defects in mac5a null mutants, including fewer stamens and male sterility. MAC5A was predominantly expressed in pollen grains and stamens, and overexpression of MAC5A affected the expression of homeotic genes such as APETALA1 (AP1), AP2, and AGAMOUS (AG). MAC5A may interact with RABBIT EARS (RBE), a repressor of AG expression in Arabidopsis flowers. The petal defect in rbe null mutants was at least partly rescued in mac5a rbe double mutants. These findings suggest that MAC5A is a novel factor that is required for the normal development of stamens and depends on the GA signaling pathway.


Asunto(s)
Flores/efectos de los fármacos , Giberelinas/farmacología , Proteínas de Unión al ARN/genética , Proteínas de Unión al ARN/metabolismo , Flores/genética , Flores/metabolismo , Regulación de la Expresión Génica de las Plantas/efectos de los fármacos , Genes Homeobox/efectos de los fármacos , Genes Homeobox/genética , Genes de Plantas/efectos de los fármacos , Genes de Plantas/genética , Morfogénesis/efectos de los fármacos , Morfogénesis/genética , Proteínas de Plantas/genética , Proteínas de Plantas/metabolismo , Polen/efectos de los fármacos , Polen/genética , Factores de Transcripción/genética , Factores de Transcripción/metabolismo
2.
Mol Med Rep ; 23(6)2021 06.
Artículo en Inglés | MEDLINE | ID: mdl-33846772

RESUMEN

The abnormal expression of tropomyosin receptor kinase (Trk) serves an important role in the promotion of cancer progression. Homeobox C6 (HOXC6) and A disintegrin and metalloproteinase domain­containing 8 (ADAM8) are associated with the invasiveness of cancer cells. However, the exact relationship between these molecules and their downstream signaling pathways in chemoresistant colon cancer cells are largely unknown. Therefore, the current study investigated the association between TrkB/C with HOXC6 and ADAM8 in the induction of drug­resistant colon cancer cell metastasis. The results demonstrated that chemoresistant colon cancer cells exhibited upregulated TrkB/C, HOXC6 and ADAM8 expression. Additionally, but also chemoresistant colon cancer cells demonstrated higher migratory activities compared with parent colon cancer cells. The pharmacological inhibition of TrkB/C activity reduced the phosphorylation of mitogen­activated protein kinase kinase/ERK and subsequently suppressed HOXC6 and ADAM8 expression. In addition, gene silencing of HOXC6 inhibited ADAM8 and MMP activity, and inhibited the migration and invasion of drug­resistant cancer cells. However, the targeted downregulation of ADAM8 using small interfering RNA failed to suppress TrkB/C­associated ERK­mediated HOXC6 signaling activity. Furthermore, pre­treatment with ADAM10­ and ADAM17­specific inhibitors had no effect on attenuating the invasiveness of chemoresistant colon cancer cells. The results indicated that TrkB/C­mediated ERK activation serves an important role in the metastasis of drug­resistant colon cancer cells through the regulation of HOXC6/ADAM8 activity.


Asunto(s)
Proteínas ADAM/metabolismo , Neoplasias del Colon/metabolismo , Genes Homeobox/efectos de los fármacos , Proteínas de Homeodominio/metabolismo , Glicoproteínas de Membrana/metabolismo , Proteínas de la Membrana/metabolismo , Receptor trkB/metabolismo , Receptor trkC/metabolismo , Proteínas ADAM/genética , Proteína ADAM10 , Proteína ADAM17 , Antineoplásicos/farmacología , Línea Celular Tumoral , Movimiento Celular/efectos de los fármacos , Neoplasias del Colon/genética , Regulación Neoplásica de la Expresión Génica/efectos de los fármacos , Proteínas de Homeodominio/genética , Humanos , Glicoproteínas de Membrana/genética , Glicoproteínas de Membrana/farmacología , Proteínas de la Membrana/genética , Receptor trkB/genética , Receptor trkB/farmacología , Receptor trkC/genética , Receptor trkC/farmacología , Transducción de Señal , Regulación hacia Arriba
3.
Endocr Regul ; 54(3): 196-206, 2020 Jul 01.
Artículo en Inglés | MEDLINE | ID: mdl-32857719

RESUMEN

OBJECTIVE: The aim of the present investigation was to study the expression of genes encoding homeobox proteins ZEB2 (zinc finger E-box binding homeobox 2), TGIF1 (TGFB induced factor homeobox 1), SPAG4 (sperm associated antigen 4), LHX1 (LIM homeobox 1), LHX2, LHX6, NKX3-1 (NK3 homeobox 1), and PRRX1 (paired related homeobox 1) in U87 glioma cells in response to glucose deprivation in control glioma cells and cells with knockdown of ERN1 (endoplasmic reticulum to nucleus signaling 1), the major pathway of the endoplasmic reticulum stress signaling, for evaluation of it possible significance in the control of glioma growth through ERN1 signaling and chemoresistance. METHODS: The expression level of homeobox family genes was studied in control (transfected by vector) and ERN1 knockdown U87 glioma cells under glucose deprivation condition by real-time quantitative polymerase chain reaction. RESULTS: It was shown that the expression level of ZEB2, TGIF1, PRRX1, and LHX6 genes was up-regulated in control glioma cells treated by glucose deprivation. At the same time, the expression level of three other genes (NKX3-1, LHX1, and LHX2) was down-regulated. Furthermore, ERN1 knockdown of glioma cells significantly modified the effect glucose deprivation condition on the expression almost all studied genes. Thus, treatment of glioma cells without ERN1 enzymatic activity by glucose deprivation condition lead to down-regulation of the expression level of ZEB2 and SPAG4 as well as to more significant up-regulation of PRRX1 and TGIF1 genes. Moreover, the expression of LHX6 and NKX3-1 genes lost their sensitivity to glucose deprivation but LHX1 and LHX2 genes did not change it significantly. CONCLUSIONS: The results of this investigation demonstrate that ERN1 knockdown significantly modifies the sensitivity of most studied homeobox gene expressions to glucose deprivation condition and that these changes are a result of complex interaction of variable endoplasmic reticulum stress related and unrelated regulatory factors and contributed to glioma cell growth and possibly to their chemoresistance.


Asunto(s)
Neoplasias Encefálicas/genética , Endorribonucleasas/genética , Genes Homeobox , Glioma/genética , Glucosa/deficiencia , Proteínas Serina-Treonina Quinasas/genética , Neoplasias Encefálicas/metabolismo , Neoplasias Encefálicas/patología , Hipoxia de la Célula/genética , Línea Celular Tumoral , Metabolismo Energético/efectos de los fármacos , Metabolismo Energético/genética , Regulación Neoplásica de la Expresión Génica , Técnicas de Silenciamiento del Gen , Genes Homeobox/efectos de los fármacos , Glioma/metabolismo , Glioma/patología , Glucosa/farmacología , Proteínas de Homeodominio/genética , Proteínas de Homeodominio/metabolismo , Humanos , Transducción de Señal/genética
4.
Toxicology ; 441: 152521, 2020 08.
Artículo en Inglés | MEDLINE | ID: mdl-32534105

RESUMEN

Homeobox (Hox) genes encode homeodomain proteins, which play important roles in the development and morphological diversification of organisms including plants and animals. Perfluorinated chemicals (PFCs), which are well recognized industrial pollutants and universally detected in human and wildlife, interfere with animal development. In addition, PFCs produce a number of hepatic adverse effects, such as hepatomegaly and dyslipidemia. Homeodomain proteins profoundly contribute to liver regeneration. Hox genes serve as either oncogenes or tumor suppressor genes during target organ carcinogenesis. However, to date, no study investigated whether PFCs regulate expression of Hox genes. This study was designed to determine the regulation of Hox (including Hox-a to -d subfamily members) and paraHox [including GS homeobox (Gsx), pancreatic and duodenal homeobox (Pdx), and caudal-related homeobox (Cdx) family members] genes by PFCs including perfluorooctanoic acid (PFOA), perfluorononanoic acid (PFNA), and perfluorodecanoic acid (PFDA) in mouse liver. 46.4 mg/kg PFNA induced mRNA expression of Hoxa5, b7, c5, d10 and Pdx1 in wild-type and CAR-null mouse livers, but not in PPARα-null mouse livers, indicating a PPARα-dependent manner. PFOA, PFNA, and PFDA all induced mRNA expression of Hoxa5, b7, c5, d10, Pdx1 and Zeb2 in wild-type but not PPARα-null mouse livers. In addition, in Nrf2-null mouse livers, PFNA continued to increase mRNA expression of Hoxa5 and Pdx1, but not Hoxb7, c5 or d10. Furthermore, Wy14643, a classical PPARα agonist, induced mRNA expression of Hoxb7 and c5 in wild-type but not PPARα-null mouse livers. However, Wy14643 did not induce mRNA expression of Hoxa5, d10 or Pdx1 in either wild-type or PPARα-null mouse livers. TCPOBOP, a classical mouse CAR agonist, increased mRNA expression of Hoxb7, c5 and d10 but not Hoxa5 or Pdx1 in mouse livers. Moreover, PFNA decreased cytoplasmic and nuclear Hoxb7 protein levels in mouse livers. However, PFNA increased cytoplasmic Hoxc5 protein level but decreased nuclear Hoxc5 protein level in mouse livers. In conclusion, PFCs induced mRNA expression of several Hox genes such as Hoxb7, c5 and d10, mostly through the activation of PPARα and/or Nrf2 signaling.


Asunto(s)
Caprilatos/toxicidad , Ácidos Decanoicos/toxicidad , Fluorocarburos/toxicidad , Genes Homeobox/efectos de los fármacos , Hígado/efectos de los fármacos , Animales , Western Blotting , Ácidos Grasos , Regulación de la Expresión Génica/efectos de los fármacos , Hígado/metabolismo , Masculino , Ratones , Ratones Endogámicos C57BL , Ratones Transgénicos , PPAR alfa/antagonistas & inhibidores , PPAR alfa/metabolismo , Pirimidinas/farmacología , Reacción en Cadena en Tiempo Real de la Polimerasa
5.
Stem Cells Dev ; 26(22): 1637-1647, 2017 11 15.
Artículo en Inglés | MEDLINE | ID: mdl-28911263

RESUMEN

Embryonic stem cells typically show properties of long-term self-renewal and lack of differentiation. When appropriately stimulated, they are able to differentiate into all cell lineages, and lose their self-renewal characteristics. These properties are controlled by a series of genes encoding several transcription factors, including OCT4, the product of POU5F1 gene. OCT4 is expressed in germ cell tumors but also aberrantly in cancers developing in differentiated tissues. In a previous study, we observed a high expression of OCT4 in acute myeloid cell lines and primary cells, regardless of the acute myeloid leukemia (AML) subtype. In this study, we investigated the putative oncogenic role of OCT4 in proliferation and differentiation arrest. OCT4 expression was assessed in a panel of myeloid cell lines, together with clonogenic and proliferation properties, before and after differentiation in the presence of retinoic acid (RA). Same experiments were performed under short hairpin RNA (shRNA)-mediated OCT4 inhibition. In the presence of RA, we observed a decrease of OCT4 expression, associated with a loss of clonogenic and proliferation capacities, cell cycle arrest, and upregulation of p21, in HL60, NB4, KASUMI, and Me-1 cell lines. This effect was absent in the KG1a cell line, which did not differentiate. Downregulation of OCT4 by shRNA resulted in the same pattern of differentiation and loss of proliferation. Although KG1a did not differentiate, a decrease in proliferation was observed. Our findings suggest that OCT4 is implicated in the differentiation arrest at least in some types of AML, and that it also plays a role in cell proliferation through different oncogenic mechanisms. OCT4 might be a potential new target for antileukemic treatments.


Asunto(s)
Leucemia Mieloide Aguda/patología , Factor 3 de Transcripción de Unión a Octámeros/metabolismo , Apoptosis/efectos de los fármacos , Puntos de Control del Ciclo Celular/efectos de los fármacos , Diferenciación Celular/efectos de los fármacos , Línea Celular Tumoral , Linaje de la Célula/efectos de los fármacos , Proliferación Celular/efectos de los fármacos , Transformación Celular Neoplásica , Regulación hacia Abajo/efectos de los fármacos , Genes Homeobox/efectos de los fármacos , Humanos , Tretinoina/farmacología
6.
Dev Biol ; 428(2): 293-299, 2017 08 15.
Artículo en Inglés | MEDLINE | ID: mdl-28728680

RESUMEN

Hox genes are crucial players in the generation and pattering of the vertebrate trunk and posterior body during embryogenesis. Their initial expression takes place shortly after the establishment of the primitive streak, in the posterior-most part of the mouse embryo and is a determinant step for setting up the definitive Hox expression boundaries along the antero-posterior body axis. The developmental signals and epigenetic mechanisms underlying this early activation remained unsolved until recently. The development of novel embryo-derived model systems, combined with methods that examine chromatin status and chromosome conformation, led to deeper understanding of the process of Hox activation in the early embryo. Here we summarize how the early Hox cis-regulatory landscape becomes active upon receiving the appropriate developmental signal, and we discuss the importance of the local topological segmentation of the HoxA cluster during early Hox activation.


Asunto(s)
Genes Homeobox , Animales , Tipificación del Cuerpo/genética , Inducción Embrionaria/genética , Regulación del Desarrollo de la Expresión Génica/efectos de los fármacos , Genes Homeobox/efectos de los fármacos , Humanos , Ratones , Modelos Genéticos , Familia de Multigenes/efectos de los fármacos , Activación Transcripcional , Tretinoina/metabolismo , Tretinoina/farmacología
7.
Curr Mol Med ; 16(1): 83-90, 2016.
Artículo en Inglés | MEDLINE | ID: mdl-26695692

RESUMEN

Pancreatic ductal adenocarcinoma (PDAC) is one of the most potent and perilous diseases known, with a median survival rate of 3-5 months due to the combination of only advanced stage diagnosis and ineffective therapeutic options. Metformin (1,1-Dimethylbiguanide hydrochloride), the leading drug used for type 2 diabetes mellitus, emerges as a potential therapy for PDAC and other human cancers. Metformin exerts its anticancer action via a variety of adenosine monophosphate (AMP)-activated protein kinase (AMPK)- dependent and/or AMPK-independent mechanisms. We present data here showing that metformin downregulated pancreatic transcription factor pancreatic duodenal homeobox-1 (PDX-1), suggesting a potential novel mechanism by which metformin exerts its anticancer action. Metformin inhibited PDX-1 expression at both protein and mRNA levels and PDX-1 transactivity as well in PDAC cells. Extracellular signal-regulated kinase (ERK) was identified as a PDX-1-interacting protein by antibody array screening in GFP-PDX-1 stable HEK293 cells. Co-transfection of ERK1 with PDX-1 resulted in an enhanced PDX-1 expression in HEK293 cells in a dose-dependent manner. Immunoprecipitation/Western blotting analysis confirmed the ERK-PDX-1 interaction in PANC-1 cells stimulated by epidermal growth factor (EGF). EGF induced an enhanced PDX-1 expression in PANC-1 cells and this stimulation was inhibited by MEK inhibitor PD0325901. Metformin inhibited EGF-stimulated PDX-1 expression with an accompanied inhibition of ERK kinase activation in PANC- 1 cells. Taken together, our studies show that PDX-1 is a potential novel target for metformin in PDAC cells and that metformin may exert its anticancer action in PDAC by down-regulating PDX-1 via a mechanism involving inhibition of ERK signaling.


Asunto(s)
Adenocarcinoma/tratamiento farmacológico , Carcinoma Ductal Pancreático/tratamiento farmacológico , Proteínas de Homeodominio/metabolismo , Sistema de Señalización de MAP Quinasas/efectos de los fármacos , Metformina/farmacología , Neoplasias Pancreáticas/tratamiento farmacológico , Transactivadores/metabolismo , Adenocarcinoma/metabolismo , Carcinoma Ductal Pancreático/metabolismo , Línea Celular , Línea Celular Tumoral , Diabetes Mellitus Tipo 2/metabolismo , Regulación hacia Abajo/efectos de los fármacos , Factor de Crecimiento Epidérmico/metabolismo , Quinasas MAP Reguladas por Señal Extracelular , Genes Homeobox/efectos de los fármacos , Células HEK293 , Humanos , Páncreas/efectos de los fármacos , Páncreas/metabolismo , Neoplasias Pancreáticas/metabolismo , Inhibidores de Proteínas Quinasas/farmacología , Transducción de Señal/efectos de los fármacos , Neoplasias Pancreáticas
8.
J Biol Chem ; 286(5): 3250-60, 2011 Feb 04.
Artículo en Inglés | MEDLINE | ID: mdl-21087926

RESUMEN

Retinoic acid (RA) regulates clustered Hox gene expression during embryogenesis and is required to establish the anterior-posterior body plan. Using mutant embryonic stem cell lines deficient in the RA receptor γ (RARγ) or Hoxa1 3'-RA-responsive element, we studied the kinetics of transcriptional and epigenomic patterning responses to RA. RARγ is essential for RA-induced Hox transcriptional activation, and deletion of its binding site in the Hoxa1 enhancer attenuates transcriptional and epigenomic activation of both Hoxa and Hoxb gene clusters. The kinetics of epigenomic reorganization demonstrate that complete erasure of the polycomb repressive mark H3K27me3 is not necessary to initiate Hox transcription. RARγ is not required to establish the bivalent character of Hox clusters, but RA/RARγ signaling is necessary to erase H3K27me3 from activated Hox genes during embryonic stem cell differentiation. Highly coordinated, long range epigenetic Hox cluster reorganization is closely linked to transcriptional activation and is triggered by RARγ located at the Hoxa1 3'-RA-responsive element.


Asunto(s)
Células Madre Embrionarias/citología , Epigenómica , Genes Homeobox/efectos de los fármacos , Proteínas de Homeodominio/genética , Factores de Transcripción/genética , Animales , Cromosomas , Genes Homeobox/genética , Ratones , Familia de Multigenes , Receptores de Ácido Retinoico/metabolismo , Elementos de Respuesta , Transcripción Genética , Activación Transcripcional , Receptor de Ácido Retinoico gamma
9.
Mol Pharmacol ; 76(5): 1072-81, 2009 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-19679824

RESUMEN

Epigenetic therapy of cancer using inhibitors of DNA methyltransferases (DNMT) or/and histone deacetylases (HDACs) has shown promising results in preclinical models and is being investigated in clinical trials. Homeodomain proteins play important roles in normal development and carcinogenesis. In this study, we demonstrated for the first time that an epigenetic drug could up-regulate homeobox genes in the reproductive homeobox genes on chromosome X (Rhox) family, including murine Rhox5, Rhox6, and Rhox9 and human RhoxF1 and RhoxF2 in breast, colon, and other types of cancer cells. We examined the molecular mechanisms underlining selective induction of Rhox5 in cancer cells by three epigenetic drugs: 5-aza-2'-deoxycytidine (DAC; decitabine), arsenic trioxide (ATO), and MS-275 [entinostat; N-(2-aminophenyl)-4-[N-(pyridine-3-ylmethoxy-carbonyl)aminomethyl]benzamide]. DAC induced Rhox5 mRNA expression from both distal promoter (Pd) and proximal promoter, whereas MS-275 and ATO induced gene expression from the Pd only. DAC and ATO inhibited both DNMT1 and DNMT3B protein expression, whereas MS-275 significantly reduced DNMT3B protein. In contrast to DAC, neither MS-275 nor ATO induced DNA demethylation on the Pd region. All three drugs led to enhanced acetylation of histones H3 and H4 at the promoter region. The occupancy of the activating histone mark dimethylated lysine 4 of H3 at Pd was enhanced by DAC and MS-275 but not ATO. Because they modulate gene expression with different potencies through shared and distinct epigenetic mechanisms, these epigenetic drugs may possess great potential in different applications for epigenetic therapy of cancer and other diseases.


Asunto(s)
Epigénesis Genética/fisiología , Genes Homeobox/fisiología , Proteínas de Homeodominio/biosíntesis , Proteínas de Homeodominio/genética , Factores de Transcripción/biosíntesis , Factores de Transcripción/genética , Regulación hacia Arriba/fisiología , Animales , Trióxido de Arsénico , Arsenicales/farmacología , Azacitidina/análogos & derivados , Azacitidina/farmacología , Benzamidas/farmacología , Línea Celular Tumoral , Metilasas de Modificación del ADN/antagonistas & inhibidores , Decitabina , Epigénesis Genética/efectos de los fármacos , Genes Homeobox/efectos de los fármacos , Inhibidores de Crecimiento/farmacología , Inhibidores de Histona Desacetilasas , Humanos , Masculino , Ratones , Óxidos/farmacología , Piridinas/farmacología , Regulación hacia Arriba/efectos de los fármacos
10.
Endocrinology ; 150(7): 3376-82, 2009 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-19299448

RESUMEN

Diethylstilbestrol (DES) is a nonsteroidal estrogen that induces developmental anomalies of the female reproductive tract. The homeobox gene HOXA10 controls uterine organogenesis, and its expression is altered after in utero DES exposure. We hypothesized that an epigenetic mechanism underlies DES-mediated alterations in HOXA10 expression. We analyzed the expression pattern and methylation profile of HOXA10 after DES exposure. Expression of HOXA10 is increased in human endometrial cells after DES exposure, whereas Hoxa10 expression is repressed and shifted caudally from its normal location in mice exposed in utero. Cytosine guanine dinucleotide methylation frequency in the Hoxa10 intron was higher in DES-exposed offspring compared with controls (P = 0.017). The methylation level of Hoxa10 was also higher in the caudal portion of the uterus after DES exposure at the promoter and intron (P < 0.01). These changes were accompanied by increased expression of DNA methyltransferases 1 and 3b. No changes in methylation were observed after in vitro or adult DES exposure. DES has a dual mechanism of action as an endocrine disruptor; DES functions as a classical estrogen and directly stimulates HOXA10 expression with short-term exposure, however, in utero exposure results in hypermethylation of the HOXA10 gene and long-term altered HOXA10 expression. We identify hypermethylation as a novel mechanism of DES-induced altered developmental programming.


Asunto(s)
Dietilestilbestrol/toxicidad , Epigénesis Genética , Genes Homeobox/efectos de los fármacos , Proteínas de Homeodominio/metabolismo , Efectos Tardíos de la Exposición Prenatal , Útero/embriología , Animales , Secuencia de Bases , ADN (Citosina-5-)-Metiltransferasas/biosíntesis , Metilación de ADN/efectos de los fármacos , Dietilestilbestrol/farmacología , Femenino , Regulación del Desarrollo de la Expresión Génica/efectos de los fármacos , Proteínas Homeobox A10 , Humanos , Ratones , Datos de Secuencia Molecular , Embarazo , ADN Metiltransferasa 3B
11.
Biol Reprod ; 80(5): 935-43, 2009 May.
Artículo en Inglés | MEDLINE | ID: mdl-19164171

RESUMEN

Nuclear transfer has been regarded as the only reliable tool for studying nuclear reprogramming of mammalian somatic cells by oocytes. However, nuclear transfer is not well suited for biochemical analyses of the molecular mechanisms of reprogramming. A cell-free system from oocytes is an attractive alternative way to mimic reprogramming in vitro, since a large number of cells can be treated and analyzed. Nevertheless, a cell-free system using oocytes has not been developed in mammals. Here, cell extracts from porcine oocytes were prepared and their ability to induce nuclear reprogramming was evaluated. Extracts from metaphase II (MII) oocytes erased the machinery for regulating gene expression in reversibly permeabilized somatic cells. For example, the extracts caused histone deacetylation and the disappearance of TATA box-binding protein from the nuclei. However, MII-extract-treated cells did not show any obvious changes after cell culture. In contrast, extracts from germinal vesicle (GV) oocytes activated pluripotent marker genes, especially NANOG, and induced partial dedifferentiation after cell culture. The activation of pluripotent marker genes by GV extracts was associated with histone acetylation that was induced during extract treatment. These results indicate that GV- and MII-oocyte extracts have different roles on nuclear reprogramming. Furthermore, both oocyte extracts induced site-specific demethylation in the upstream region of NANOG. These results indicate that cell-free extracts derived from GV- and MII-oocytes could be useful for studying the mechanisms involved in nuclear reprogramming.


Asunto(s)
Núcleo Celular/efectos de los fármacos , Núcleo Celular/metabolismo , Reprogramación Celular/efectos de los fármacos , Oocitos/metabolismo , Acetilación/efectos de los fármacos , Animales , Diferenciación Celular/efectos de los fármacos , Extractos Celulares/farmacología , Sistema Libre de Células , Células Cultivadas , Reprogramación Celular/genética , Reprogramación Celular/fisiología , Metilación de ADN/efectos de los fármacos , Femenino , Genes Homeobox/efectos de los fármacos , Histonas/metabolismo , Técnicas In Vitro , Sus scrofa , Activación Transcripcional/efectos de los fármacos
12.
Birth Defects Res A Clin Mol Teratol ; 85(1): 36-41, 2009 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-19086026

RESUMEN

BACKGROUND: Dominant hemimelia (Dh) is an autosomal dominant mutation that arose spontaneously in mice. Dh animals are asplenic and they exhibit asymmetric hindlimb defects in association with reduced numbers of lumbar vertebrae. These defects suggest that Dh acts early in embryonic development to affect patterning of the anterior-posterior (A-P) and left-right axes. This study was undertaken to determine whether retinoic acid (RA), which is involved in A-P patterning and coordination of bilaterally synchronized somitogenesis, affects phenotypic expression of the Dh gene. METHODS: Thirty-four pregnant females were given, by oral intubation, a single dose of 50 or 75 mg all-trans RA per kilogram body weight at GD 9, 10, or 11. The pregnant females were then euthanized at GD 18 and fetuses removed by cesarean section. A total of 326 fetuses were identified by phenotype and linked DNA and their skeletons were analyzed. RESULTS: There was a differential effect of RA on the axial skeleton and hindlimb of Dh/+ mice as compared to their wild-type littermates. Dose- and stage-specific effects on sternebrae and vertebrae were observed. CONCLUSIONS: The effects of RA dosing on numbers of sternebrae and vertebrae suggest that Dh embryos have a primary defect in retinoid-mediated A-P patterning. Dosing with RA may produce the observed effects on phenotypic expression of Dh/+ by indirectly or directly modifying an already existing altered Hox expression pattern. As the relationship between axial patterning and the asymmetric limb is unknown, Dh is an important model for studying this relationship.


Asunto(s)
Ectromelia/genética , Regulación del Desarrollo de la Expresión Génica , Genes Dominantes , Genes Homeobox , Tretinoina/toxicidad , Anomalías Inducidas por Medicamentos/genética , Animales , Tipificación del Cuerpo/efectos de los fármacos , Relación Dosis-Respuesta a Droga , Ectromelia/patología , Femenino , Genes Homeobox/efectos de los fármacos , Genes Homeobox/genética , Genes Homeobox/fisiología , Proteínas de Homeodominio , Ratones , Ratones Endogámicos C3H , Ratones Endogámicos C57BL , Embarazo , Columna Vertebral/anomalías , Columna Vertebral/efectos de los fármacos , Columna Vertebral/embriología , Tretinoina/administración & dosificación
13.
Development ; 135(19): 3197-207, 2008 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-18715948

RESUMEN

The Iroquois (Irx) genes encode evolutionary conserved homeoproteins. We report that Xenopus genes Irx1 and Irx3 are expressed and required during different stages of Xenopus pronephros development. They are initially expressed during mid-neurulation in domains extending over most of the prospective pronephric territory. Expression onset takes place after kidney anlage specification, but before pronephric organogenesis occurs. Later, during nephron segmentation, expression becomes restricted to the intermediate tubule region of the proximal-distal axis. Loss- and gain-of-function analyses, performed with specific morpholinos and inducible wild-type and dominant-negative constructs, reveal a dual requirement for Irx1 and Irx3 during pronephros development. During neurula stages, these genes maintain the specification of the pronephric territory and define its size. This seems to occur, at least in part, through positive regulation of Bmp signalling. Subsequently, Irx genes are required for proper formation of the intermediate tubule. Finally, we find that retinoic acid signalling activates both Irx1 and Irx3 genes in the pronephros.


Asunto(s)
Genes Homeobox , Riñón/embriología , Riñón/metabolismo , Xenopus laevis/embriología , Xenopus laevis/genética , Animales , Secuencia de Bases , Tipificación del Cuerpo/efectos de los fármacos , Tipificación del Cuerpo/genética , Proteínas Morfogenéticas Óseas/genética , Proteínas Morfogenéticas Óseas/metabolismo , Cartilla de ADN/genética , Regulación del Desarrollo de la Expresión Génica/efectos de los fármacos , Genes Homeobox/efectos de los fármacos , Proteínas de Homeodominio/antagonistas & inhibidores , Proteínas de Homeodominio/genética , Proteínas del Tejido Nervioso/antagonistas & inhibidores , Proteínas del Tejido Nervioso/genética , ARN Mensajero/genética , ARN Mensajero/metabolismo , Transducción de Señal , Factores de Transcripción/antagonistas & inhibidores , Factores de Transcripción/genética , Tretinoina/farmacología , Proteínas de Xenopus/antagonistas & inhibidores , Proteínas de Xenopus/genética , Proteínas de Xenopus/metabolismo , Xenopus laevis/metabolismo
14.
Toxicol In Vitro ; 22(6): 1447-51, 2008 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-18534812

RESUMEN

Cadmium (Cd) is a serious toxic metal, which is classified as a possible human carcinogen. We assessed the effects of Cd on the expression levels of homeobox genes, which are associated with carcinogenesis. Among 6 homeobox genes examined in this study, only HOXB8 exhibited increased mRNA expression in COS-7 cells treated with 10 microM CdCl(2). Semiquantitative reverse transcription-polymerase chain reaction analysis revealed that the HOXB8 mRNA level was increased by a maximum of 5.4-fold after 6h of Cd exposure. The levels of HOXA7, A9, C4, C9 and C10 mRNAs decreased from 0.1 to 0.3-fold. Silencing of HOXB8 mRNA expression using a siRNA increased HOXC9 and C10 mRNA expression levels by 6.6- and 1.9-fold, respectively. These results suggest that HOXB8 upregulation is associated with suppression of HOXC9 and C10, and that decreased expression of HOXC9 and C10 after Cd exposure is partly due to HOXB8 induction. In conclusion, Cd disrupts the HOX network. Comprehensive analyses of all the HOX gene expression levels in the presence of Cd may afford clues toward understanding Cd-induced carcinogenesis and teratogenesis.


Asunto(s)
Cadmio/toxicidad , Carcinógenos/toxicidad , Regulación de la Expresión Génica/efectos de los fármacos , Genes Homeobox/efectos de los fármacos , Animales , Células COS , Chlorocebus aethiops , Silenciador del Gen/efectos de los fármacos , Humanos , ARN Mensajero/efectos de los fármacos , ARN Mensajero/metabolismo , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa
15.
Birth Defects Res A Clin Mol Teratol ; 79(9): 642-51, 2007 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-17647295

RESUMEN

BACKGROUND: Exposure of zebrafish embryos to a number of teratogens results in cyclopia, but little is known about the underlying molecular changes. METHODS: Using zebrafish embryos, we compare the effects cyclopamine, forskolin, and ethanol delivered starting just before gastrulation, on gene expression in early axial tissues and forebrain development. RESULTS: Although all three teratogens suppress gli1 expression, they do so with variable kinetics, suggesting that while suppression of Shh signaling is a common outcome of these three teratogens, it is not a common cause of the cyclopia. Instead, all teratogens studied produce a series of changes in the expression of gsc and six3b present in early axial development, as well as a later suppression of neural crest cell marker dlx3b. Ethanol and forskolin, but not cyclopamine, exposure reduced anterior markers, which most likely contributes to the cyclopic phenotype. CONCLUSIONS: These data suggest that each teratogen exposure leads to a unique set of molecular changes that underlie the single phenotype of cyclopia.


Asunto(s)
Anomalías del Ojo/inducido químicamente , Anomalías del Ojo/genética , Teratógenos/toxicidad , Animales , Secuencia de Bases , Colforsina/toxicidad , Cartilla de ADN/genética , Etanol/toxicidad , Anomalías del Ojo/embriología , Proteínas del Ojo/genética , Regulación del Desarrollo de la Expresión Génica/efectos de los fármacos , Genes Homeobox/efectos de los fármacos , Proteína Goosecoide/genética , Proteínas Hedgehog/genética , Proteínas de Homeodominio/genética , Factores de Transcripción de Tipo Kruppel/genética , Proteínas del Tejido Nervioso/genética , Alcaloides de Veratrum/toxicidad , Pez Cebra/embriología , Pez Cebra/genética , Proteínas de Pez Cebra/genética , Proteína Homeobox SIX3
16.
Gut ; 55(1): 16-25, 2006 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-16118348

RESUMEN

BACKGROUND AND AIMS: The mechanism of transformation to intestinal metaplasia in Barrett's oesophagus has not been clarified. We investigated the effects of various bile acids on expression of the caudal related homeobox gene Cdx2 in cultured oesophageal squamous epithelial cells. In addition, morphological and histochemical changes in squamous cells to intestinal epithelial cells were studied in response to bile acid induced expression of Cdx2. METHODS: A rat model of Barrett's oesophagus was created by anastomosing the oesophagus and jejunum, and Cdx2 expression was investigated by immunohistochemistry. Also, the response of various bile acids on Cdx2 gene expression was studied in the human colon epithelial cell lines Caco-2 and HT-29, as well as in cultured rat oesophageal squamous epithelial cells using a Cdx2 promoter luciferase assay. In addition, primary cultured oesophageal squamous epithelial cells were transfected with Cdx2 expression vectors and their possible transformation to intestinal-type epithelial cells was investigated. RESULTS: Oesophagojejunal anastomoses formed intestinal goblet cell metaplasia in rat oesophagus specimens and metaplastic epithelia strongly expressed Cdx2. When the effects of 11 types of bile acids on Cdx2 gene expression were examined, only cholic acid (CA) and dehydrocholic acid dose dependently increased Cdx2 promoter activity and Cdx2 protein production in Caco-2 and HT-29 cells, and cultured rat oesophageal keratinocytes. Results from mutation analysis of Cdx2 promoter suggested that two nuclear factor kappaB (NFkappaB) binding sites were responsible for the bile acid induced activation of the Cdx2 promoter. When bile acids were measured in oesophageal refluxate of rats with experimental Barrett's oesophagus, the concentration of CA was found to be consistent with the experimental dose that augmented Cdx2 expression in vitro. Furthermore, transfection of the Cdx2 expression vector in cultured rat oesophageal keratinocytes induced production of intestinal-type mucin, MUC2, in cells that expressed Cdx2. CONCLUSIONS: We found that CA activates Cdx2 promoter via NFkappaB and stimulates production of Cdx2 protein in oesophageal keratinocytes with production of intestinal-type mucin. This may be one of the mechanisms of metaplasia in Barrett's oesophagus.


Asunto(s)
Esófago de Barrett/patología , Ácidos y Sales Biliares/farmacología , Proteínas de Homeodominio/metabolismo , Queratinocitos/efectos de los fármacos , Animales , Esófago de Barrett/metabolismo , Ácidos y Sales Biliares/análisis , Northern Blotting , Factor de Transcripción CDX2 , Células Cultivadas , Ácido Cólico/farmacología , Modelos Animales de Enfermedad , Contenido Digestivo/química , Regulación de la Expresión Génica/efectos de los fármacos , Genes Homeobox/efectos de los fármacos , Genes Reporteros , Proteínas de Homeodominio/genética , Humanos , Queratinocitos/metabolismo , Masculino , Regiones Promotoras Genéticas , Ratas , Ratas Wistar , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa/métodos
17.
Brain Res Dev Brain Res ; 154(1): 63-70, 2005 Jan 01.
Artículo en Inglés | MEDLINE | ID: mdl-15617756

RESUMEN

Recent embryological studies have implicated several "caudalizing factors" in the caudal specification of the central nervous system (CNS). In this study, we have examined the effects of three candidate caudalizing factors on neural precursors induced from embryonic stem (ES) cells by the stromal cell-derived inducing activity (SDIA) method. Among retinoic acid (RA), Wnt and FGF signals, RA causes the strongest level of caudalization: inducing suppression of forebrain differentiation and promotion of caudal CNS specification. Obvious suppression of the telencephalic marker Bf1 and that of the forebrain marker Otx2 occur at 2x10(-8) and 2x10(-7) M, respectively. Activation of the caudal marker genes such as Hoxb9 is observed in a dose-dependent manner over the range of 2x10(-9)-2x10(-6) M. Suppression of the forebrain genes has a narrow critical period of RA response during the early culture phase. In contrast, significant induction of the caudal genes is evoked by a 1-day exposure to RA at any time between days 3 and 8. RA treatment not only induces caudal specification but also inhibits differentiation of ventral CNS tissues, particularly of floor plate cells. FGF4 induces partial caudalization while Wnt-3A exhibits weak caudalizing activities only in the presence of RA. These findings provide useful information on the proper selection of combination of signaling molecules, doses and timing for steering ES cell differentiation by caudalizing factors into caudal neural fates.


Asunto(s)
Tipificación del Cuerpo/fisiología , Diferenciación Celular/genética , Sistema Nervioso Central/embriología , Sustancias de Crecimiento/metabolismo , Neuronas/metabolismo , Células Madre/metabolismo , Animales , Tipificación del Cuerpo/efectos de los fármacos , Diferenciación Celular/efectos de los fármacos , Línea Celular , Sistema Nervioso Central/citología , Sistema Nervioso Central/metabolismo , Proteínas de Unión al ADN/genética , Relación Dosis-Respuesta a Droga , Factor 4 de Crecimiento de Fibroblastos , Factores de Crecimiento de Fibroblastos/metabolismo , Factores de Crecimiento de Fibroblastos/farmacología , Factores de Transcripción Forkhead , Regulación del Desarrollo de la Expresión Génica/efectos de los fármacos , Regulación del Desarrollo de la Expresión Génica/genética , Marcación de Gen , Genes Homeobox/efectos de los fármacos , Genes Homeobox/genética , Sustancias de Crecimiento/farmacología , Proteínas de Homeodominio/genética , Ratones , Proteínas del Tejido Nervioso/genética , Neuronas/citología , Factores de Transcripción Otx , Proteínas/metabolismo , Proteínas/farmacología , Proteínas Proto-Oncogénicas/metabolismo , Proteínas Proto-Oncogénicas/farmacología , Células Madre/citología , Tretinoina/metabolismo , Tretinoina/farmacología , Proteínas Wnt , Proteína Wnt3 , Proteína Wnt3A
18.
Proc Natl Acad Sci U S A ; 101(28): 10320-5, 2004 Jul 13.
Artículo en Inglés | MEDLINE | ID: mdl-15226493

RESUMEN

In developing chordates, retinoic acid (RA) signaling patterns the rostrocaudal body axis globally and affects gene expression locally in some differentiating cell populations. Here we focus on development of epidermal sensory neurons in an invertebrate chordate (amphioxus) to determine how RA signaling influences their rostrocaudal distribution and gene expression (for AmphiCoe, a neural precursor gene; for amphioxus islet and AmphiERR, two neural differentiation genes; and for AmphiHox1, -3, -4, and -6). Treatments with RA or an RA antagonist (BMS009) shift the distribution of developing epidermal neurons anteriorly or posteriorly, respectively. These treatments also affect gene expression patterns in the epidermal neurons, suggesting that RA levels may influence specification of neuronal subtypes. Although colinear expression of Hox genes is well known for the amphioxus central nervous system, we find an unexpected comparable colinearity for AmphiHox1, -3, -4, and -6 in the developing epidermis; moreover, RA levels affect the anteroposterior extent of these Hox expression domains, suggesting that RA signaling controls a colinear Hox code for anteroposterior patterning of the amphioxus epidermis. Thus, in amphioxus, the developing peripheral nervous system appears to be structured by mechanisms parallel to those that structure the central nervous system. One can speculate that, during evolution, an ancestral deuterostome that structured its panepidermal nervous system with an RA-influenced Hox code gave rise to chordates in which this patterning mechanism persisted within the epidermal elements of the peripheral nervous system and was transferred to the neuroectoderm as the central nervous system condensed dorsally.


Asunto(s)
Antineoplásicos/farmacología , Cordados no Vertebrados/embriología , Regulación del Desarrollo de la Expresión Génica/efectos de los fármacos , Genes Homeobox/efectos de los fármacos , Tretinoina/farmacología , Animales , Antineoplásicos/antagonistas & inhibidores , Cordados no Vertebrados/fisiología , Epidermis/embriología , Epidermis/inervación , Femenino , Masculino , Sistema Nervioso/embriología , Neuronas Aferentes/fisiología , Transducción de Señal/fisiología , Tretinoina/antagonistas & inhibidores
19.
J Periodontol ; 75(2): 260-7, 2004 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-15068114

RESUMEN

BACKGROUND: Enamel matrix derivative (EMD) has recently been developed for use as a periodontal regenerative treatment. While EMD is believed to induce regeneration of periodontal tissue, the precise mechanism is not known. Bone sialoprotein (BSP), an early phenotypic marker of osteoblast differentiation, has been implicated in the nucleation of hydroxyapatite during bone formation. In this study, we examined the ability of EMD to regulate BSP gene transcription in osteoblast-like cells. METHODS: To determine the molecular basis of the transcriptional regulation of BSP gene transcription by EMD, we conducted Northern hybridization, transient transfection analyses with chimeric constructs of the rat BSP gene promoter linked to a luciferase reporter gene, and gel mobility shift assays. RESULTS: Using the osteoblastic cell line ROS 17/2.8, we determined that BSP mRNA levels increased approximately 2.8-fold by EMD. In transient transfection analyses, EMD (50 microg/ml, 12 hours) increased luciferase activities of pLUC4 (nt -425 to +60) and pLUC5 (nt -801 to +60), transfected into ROS 17/2.8 cells. Within the pLUC4 and 5, a homeodomain binding element (HOX) and a transforming growth factor (TGF)-beta activation element (TAE) are present. Gel mobility shift assays with radiolabeled HOX and TAE ds-oligonucleotides revealed increased binding of nuclear proteins from EMD stimulated ROS 17/2.8 cells. CONCLUSION: These studies have, therefore, identified EMD response elements in the rat BSP gene promoter that may mediates the effects of EMD on BSP gene transcription.


Asunto(s)
Proteínas del Esmalte Dental/farmacología , Sialoglicoproteínas/efectos de los fármacos , Transcripción Genética/efectos de los fármacos , Animales , Células de la Médula Ósea/efectos de los fármacos , Línea Celular , Quimera/genética , Células Clonales , Elementos de Facilitación Genéticos/efectos de los fármacos , Elementos de Facilitación Genéticos/genética , Regulación de la Expresión Génica/efectos de los fármacos , Genes Homeobox/efectos de los fármacos , Genes Homeobox/genética , Sialoproteína de Unión a Integrina , Luciferasas/efectos de los fármacos , Luciferasas/genética , Osteoblastos/efectos de los fármacos , Regiones Promotoras Genéticas/efectos de los fármacos , Ratas , Elementos de Respuesta/efectos de los fármacos , Elementos de Respuesta/genética , Sialoglicoproteínas/genética , Transcripción Genética/genética , Transfección , Factor de Crecimiento Transformador beta/efectos de los fármacos , Factor de Crecimiento Transformador beta/genética
20.
Development ; 130(26): 6555-67, 2003 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-14660544

RESUMEN

Hox gene products are key players in establishing positional identity along the anteroposterior (AP) axis. In vertebrates, gain or loss of Hox expression along the AP axis often leads to inappropriate morphogenesis, typically manifesting as homeotic transformations that affect the vertebrae and/or hindbrain. Various signalling pathways are known to impact on Hox expression, including the retinoid signalling pathway. Exogenous retinoic acid (RA), disruption of enzymes involved in maintaining normal embryonic RA distribution or mutation of the retinoid receptors (RARs and RXRs) can all impact on Hox expression with concomitant effects on AP patterning. Several Hox loci have well characterized RA response elements (RAREs), which have been shown to regulate functionally relevant Hox expression in the neurectoderm. A similar crucial function for any RARE in mesodermal Hox expression has, however, not been documented. The means by which RA regulates mesodermal Hox expression could therefore be either through an undocumented direct mechanism or through an intermediary; these mechanisms are not necessarily exclusive. In this regard, we have found that Cdx1 may serve as such an intermediary. Cdx1 encodes a homeobox transcription factor that is crucial for normal somitic expression of several Hox genes, and is regulated by retinoid signalling in vivo and in vitro likely through an atypical RARE in the proximal promoter. In order to more fully understand the relationship between retinoid signalling, Cdx1 expression and AP patterning, we have derived mice in which the RARE has been functionally inactivated. These RARE-null mutants exhibit reduced expression of Cdx1 at all stages examined, vertebral homeotic transformations and altered Hox gene expression which correlates with certain of the defects seen in Cdx1-null offspring. These findings are consistent with a pivotal role for retinoid signalling in governing a subset of expression of Cdx1 crucial for normal vertebral patterning.


Asunto(s)
Regulación del Desarrollo de la Expresión Génica/efectos de los fármacos , Proteínas de Homeodominio/genética , Tretinoina/farmacología , Animales , Bacteriófago lambda/genética , Tipificación del Cuerpo/efectos de los fármacos , Tipificación del Cuerpo/genética , Cruzamientos Genéticos , Desarrollo Embrionario y Fetal/efectos de los fármacos , Desarrollo Embrionario y Fetal/genética , Femenino , Genes Homeobox/efectos de los fármacos , Genoma Viral , Hibridación in Situ , Masculino , Ratones , Ratones Endogámicos C57BL , Mapeo Restrictivo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA